Meloset
Formulated to target insomnia, indicated to improve sleep latency and help support a normalized circadian rhythm when physiological melatonin production remains insufficient.
Strengths: 3mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Circadin
- Therapeutic class
Melatonin Receptor Agonist
- Pharmacological class
Melatonin Receptor Agonist
- Contraindications
hypersensitivity to melatonin; severe hepatic impairment
- Precautions and warnings
may cause drowsiness; use with caution in elderly patients
- Minor side effects
headache; dizziness
- Moderate side effects
irritability; nervousness; insomnia
- Serious side effects
seizures — requires immediate medical attention
- Dosage forms
Prolonged-release tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Neurim Pharmaceuticals
- Onset Time
1–2 hours
- Duration
6–8 hours
- Storage instructions
Store in a cool, dry place away from direct sunlight.
- Drug interactions
Alcohol; Caffeine; Fluvoxamine
- Age restrictions
Not for use in children.
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Patient summary
Formulated to target insomnia, indicated to improve sleep latency and help support a normalized circadian rhythm when physiological melatonin production remains insufficient.
Mechanism of action
Melatonin acts on MT1, MT2, and MT3 receptors in the brain to regulate sleep-wake cycles and promote the onset of sleep through modulation of the circadian system.
Meloset
Formulated to target insomnia, indicated to improve sleep latency and help support a normalized circadian rhythm when physiological melatonin production remains insufficient.
Editorial Notes
- Active ingredient(s): Melatonin
- Listed indication(s): Insomnia